TONIX PHARMACEUTICALS HLDG C's ticker is TNXP and the CUSIP is 890260409. A total of 26 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $93,000 | – | 20,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 699,500 | $3,113,000 | 0.02% |
| DRW Securities, LLC | 20,000 | $89,000 | 0.01% |
| SG Americas Securities, LLC | 13,500 | $60,000 | 0.00% |
| Winch Advisory Services, LLC | 300 | $1,000 | 0.00% |
| Renaissance Technologies | 287,300 | $1,122,000 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 54,850 | $244,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 270 | $1,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 4,500 | $20,000 | 0.00% |
| NORTHERN TRUST CORP | 12,480 | $56,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 38,714 | $172,000 | 0.00% |